D.E. Shaw & Co
RXRX icon

D.E. Shaw & Co’s Recursion Pharmaceuticals RXRX Stock Holding History

D.E. Shaw & Co’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Sell
46,008
-43,536
-49% -$168K ﹤0.01% 4246
2025
Q4 		$366K Buy
+89,544
New +$444K ﹤0.01% 4068
2025
Q3 		– Sell
-633,403
Closed -$3.21M – 4925
2025
Q2 		$3.21M Buy
633,403
+572,497
+940% +$2.81M ﹤0.01% 2376
2025
Q1 		$322K Buy
+60,906
New +$444K ﹤0.01% 3734
2024
Q2 		– Sell
-61,963
Closed -$618K – 4846
2024
Q1 		$618K Buy
61,963
+46,904
+311% +$522K ﹤0.01% 3382
2023
Q4 		$148K Sell
15,059
-8,648
-36% -$61.7K ﹤0.01% 3925
2023
Q3 		$181K Buy
23,707
+11,862
+100% +$118K ﹤0.01% 3783
2023
Q2 		$88.5K Sell
11,845
-191,053
-94% -$1.34M ﹤0.01% 3839
2023
Q1 		$1.35M Buy
+202,898
New +$1.61M ﹤0.01% 2954

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return